In January atai Life Sciences, the German biotech company he founded last year, acquired a majority stake in Perception Neuroscience, a biopharmaceutical firm from New York which is developing a medication for pyschiatric conditions like depression from the drug, which is illegal in parts of the world.
Most people are aware of common risk factors for mental illness, such as genetics, adverse
Depression is today’s most prevalent mental health disorder and the leading cause of disability worldwide.
Last week, Srinivas Rao, MD, Chief Scientific Officer of ATAI Life Sciences, took to the
A startup backed by $80 million from investors is striking deals with a range of drug companies in its bid to lead the next wave of mental-health treatments.
Depression is a pervasive and debilitating mental health disorder that affects more than 300 million